SOLARA ACTIVE PHARMA Q2 FY27: STRATEGIC RESTRUCTURING AT ADVANCED STAGE 🟢

• Strategic Review: Board-appointed advisors have reached an advanced stage in evaluating the company's future business strategy. • Ibuprofen Business: Reviewing strategic options for its ibuprofen business as part of the restructuring. • Business Focus: Shifting towards higher-margin growth APIs, R&D, complex chemistry and lower competitive intensity . • Next Update: Management expects to announce further details within the next 12 weeks. • Value Creation: Upcoming announcement expected to outline the company's future strategy and potential value-creation opportunities.

SOLARA ACTIVE PHA SCI LTD

← Back to feed